CN111635401A - Copper complex promoted 7-fluoroimidazo [1,2-a ] pyridine synthesis method - Google Patents

Copper complex promoted 7-fluoroimidazo [1,2-a ] pyridine synthesis method Download PDF

Info

Publication number
CN111635401A
CN111635401A CN202010562549.5A CN202010562549A CN111635401A CN 111635401 A CN111635401 A CN 111635401A CN 202010562549 A CN202010562549 A CN 202010562549A CN 111635401 A CN111635401 A CN 111635401A
Authority
CN
China
Prior art keywords
pyridine
copper complex
fluoroimidazo
reaction
promoted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010562549.5A
Other languages
Chinese (zh)
Inventor
罗治斌
高苏皖
孙华
姚林荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhenjiang Cabo Medical Technology Co ltd
Original Assignee
Zhenjiang Cabo Medical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhenjiang Cabo Medical Technology Co ltd filed Critical Zhenjiang Cabo Medical Technology Co ltd
Priority to CN202010562549.5A priority Critical patent/CN111635401A/en
Publication of CN111635401A publication Critical patent/CN111635401A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1805Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
    • B01J31/181Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine
    • B01J31/1825Ligands comprising condensed ring systems, e.g. acridine, carbazole
    • B01J31/183Ligands comprising condensed ring systems, e.g. acridine, carbazole with more than one complexing nitrogen atom, e.g. phenanthroline
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/30Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
    • B01J2231/32Addition reactions to C=C or C-C triple bonds
    • B01J2231/324Cyclisations via conversion of C-C multiple to single or less multiple bonds, e.g. cycloadditions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/10Complexes comprising metals of Group I (IA or IB) as the central metal
    • B01J2531/16Copper

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention belongs to the field of organic synthesis, fine chemicals and medical intermediates, and particularly relates to a method for synthesizing 7-fluoroimidazo [1,2-a ] pyridine from 2-amino-4-fluoropyridine and acetylene, which is promoted by a copper complex. The method is characterized in that a copper complex is used as a catalyst, and under the existence of peroxide, 2-amino-4-fluoropyridine and acetylene undergo an oxidative cycloaddition reaction to synthesize the 7-fluoroimidazole [1,2-a ] pyridine. The method is simple and convenient to operate, the reagent is cheap and easy to obtain, and the method has a good industrial application prospect.

Description

Copper complex promoted 7-fluoroimidazo [1,2-a ] pyridine synthesis method
Technical Field
The invention relates to the technical field of organic synthesis and fine chemicals, in particular to a copper complex-promoted synthesis method of 7-fluoroimidazole [1,2-a ] pyridine.
Background
7-fluoroimidazo [1,2-a ] pyridine (CAS number 1260903-17-0), an important organic synthetic intermediate, is widely used in the synthesis of medicines, pesticides, and fine chemicals. For the synthesis method of 7-fluoroimidazole [1,2-a ] pyridine, although some documents report at present, several steps of reaction are often needed, the process is complex, and the cost is high. The invention provides a method for synthesizing 7-fluoroimidazole [1,2-a ] pyridine by using 2-amino-4-fluoropyridine and acetylene in one step. The method is characterized in that a copper complex is used as a catalyst, and under the existence of peroxide, 2-amino-4-fluoropyridine and acetylene generate (3 + 2) oxidation cycloaddition reaction, so that 7-fluoroimidazole [1,2-a ] pyridine is synthesized. The method is simple and convenient to operate, the reagent is cheap and easy to obtain, and the method has a good industrial application prospect.
Disclosure of Invention
The invention aims to provide a copper complex-promoted 7-fluoroimidazo [1,2-a ] pyridine synthesis method aiming at the defects in the prior art.
The technical scheme for solving the problems comprises the following steps: a copper complex promoted 7-fluoroimidazo [1,2-a ] pyridine synthesis method is a one-step synthesis method of 7-fluoroimidazo [1,2-a ] pyridine by taking 2-amino-4-fluoropyridine and acetylene as raw materials in the presence of a copper complex and peroxide. The copper complex is used as a catalyst to promote the [ 3+2 ] oxidative cycloaddition reaction of 2-amino-4-fluoropyridine and acetylene, and the specific reaction and the structural formula of the catalyst are shown in the following chart:
Figure BDA0002544766200000011
in the catalyst structure of the reaction, R1, R2, R3, R4, R5, R6 and R7 are hydrogen atoms or any of the same or different alkyl groups, aryl groups or heterocyclic groups.
In the structure of the catalyst for the reaction, [ Cu ] is copper ions with 0-1 anions, and the anions comprise chloride ions, bromide ions, iodide ions, trifluoromethanesulfonate ions, perchlorate ions, acetate ions and the like.
The amount of the catalyst substance is 1-5% of the amount of the 2-amino-4-fluoropyridine substance.
The peroxide is selected from sodium persulfate, Oxone, benzoyl peroxide and the like, and the amount ratio of the peroxide to the 2-amino-4-fluoropyridine is 1-1.2: 1.
the acetylene consumption of the reaction is measured by the pressure of acetylene gas in a reaction system, and the pressure of acetylene is kept at 1-5 standard atmospheric pressures in the reaction process.
The solvent for the reaction is selected from DMF (N, N-dimethylformamide), DMA (N, N-dimethylacetamide), DMSO (dimethyl sulfoxide), acetonitrile and the like.
The reaction temperature is 60-100 ℃.
The invention has the following beneficial effects:
the invention provides a copper complex-promoted 7-fluoroimidazo [1,2-a ] pyridine synthesis method, which is a method for synthesizing 7-fluoroimidazo [1,2-a ] pyridine by a one-step method in the presence of a copper complex and peroxide by taking 2-amino-4-fluoropyridine and acetylene as raw materials. The method is simple and convenient to operate, cheap and easily available in reagents, green, safe, efficient and environment-friendly, and is suitable for industrial production.
Drawings
FIG. 1: examples one to four nuclear magnetic resonance hydrogen spectra of the synthesized 7-fluoroimidazo [1,2-a ] pyridine.
FIG. 2: examples one to four high performance liquid chromatography of the synthesized 7-fluoroimidazo [1,2-a ] pyridine.
Detailed Description
The first embodiment is as follows:
Figure BDA0002544766200000021
112 g of 2-amino-4-fluoropyridine, 500mL of DMF as a solvent, 240 g of sodium persulfate and 6 g of catalyst were placed in succession in a 1000mL pressure reaction vessel. Then, acetylene gas was introduced while maintaining the pressure at 2 to 3 atmospheres, the reaction was carried out at 80 ℃ for 26 hours, and then, water and ethyl acetate were used for extraction three times to remove the water layer, and the organic layer was dried over anhydrous sodium sulfate. The solvent was removed by rotary evaporator to give 121 g of 7-fluoroimidazo [1,2-a ] pyridine in 89% yield.
Example two:
Figure BDA0002544766200000022
to a 1000mL pressure reaction vessel were added 112 g of 2-amino-4-fluoropyridine, 500mL of solvent DMSO, 620 g of Oxone, and 9 g of catalyst in this order. Then, acetylene gas was introduced while maintaining the pressure at 3 to 4 atmospheres, the reaction was carried out at 60 ℃ for 24 hours, and then, water and ethyl acetate were used for extraction three times to remove the water layer, and the organic layer was dried over anhydrous sodium sulfate. The solvent was removed by rotary evaporator to give 123 g of 7-fluoroimidazo [1,2-a ] pyridine in 90% yield.
Example three:
Figure BDA0002544766200000031
112 g of 2-amino-4-fluoropyridine, 500mL of acetonitrile solvent, 250 g of benzoyl peroxide and 12 g of catalyst were placed in a 1000mL pressure reaction vessel in this order. Then, acetylene gas was introduced while maintaining the pressure at 1 to 4 atmospheres, and after the reaction was carried out at a temperature of 100 ℃ for 28 hours, the reaction mixture was extracted with water and ethyl acetate three times to remove the water layer, and the organic layer was dried over anhydrous sodium sulfate. The solvent was removed by rotary evaporator to give 118 g of 7-fluoroimidazo [1,2-a ] pyridine in 87% yield.
Example four:
Figure BDA0002544766200000032
112 g of 2-amino-4-fluoropyridine, 500mL of solvent DMA, 240 g of sodium persulfate and 12 g of catalyst were placed in succession in a 1000mL pressure reaction vessel. Then, acetylene gas was introduced while maintaining the pressure at 2 to 3 atmospheres, the temperature was raised to 90 ℃ to react for 24 hours, and then water and ethyl acetate were extracted three times to remove the water layer, and the organic layer was dried over anhydrous sodium sulfate. The solvent was removed by rotary evaporator to give 125 g of 7-fluoroimidazo [1,2-a ] pyridine in 92% yield.
The structure of 7-fluoroimidazo [1,2-a ] pyridine synthesized in the above examples was confirmed by hydrogen nuclear magnetic resonance spectroscopy (1H NMR) and High Performance Liquid Chromatography (HPLC) in fig. 1 and 2.
The above description is only a preferred embodiment of the present invention, and not intended to limit the present invention in other forms, and any person skilled in the art may apply the above modifications or changes to the equivalent embodiments with equivalent changes, without departing from the technical spirit of the present invention, and any simple modification, equivalent change and change made to the above embodiments according to the technical spirit of the present invention still belong to the protection scope of the technical spirit of the present invention.

Claims (8)

1. The copper complex-promoted 7-fluoroimidazole [1,2-a ] pyridine synthesis method is characterized by comprising the following steps: a method for synthesizing 7-fluoroimidazole [1,2-a ] pyridine by using 2-amino-4-fluoropyridine and acetylene as raw materials in a one-step method in the presence of a copper complex and peroxide comprises the following specific reactions:
Figure FDA0002544766190000011
2. the copper complex-promoted synthesis of 7-fluoroimidazo [1,2-a ] pyridine as claimed in claim 1, characterized in that: in the catalyst structure used in the reaction, R1, R2, R3, R4, R5, R6 and R7 are hydrogen atoms or any of the same or different alkyl groups, aryl groups or heterocyclic groups.
3. The copper complex-promoted synthesis of 7-fluoroimidazo [1,2-a ] pyridine as claimed in claim 1, characterized in that: in the structure of the catalyst used in the reaction, [ Cu ] is copper ions with 0-1 anions, and the anions comprise chloride ions, bromide ions, iodide ions, trifluoromethanesulfonate ions, perchlorate ions and acetate ions.
4. The copper complex-promoted synthesis of 7-fluoroimidazo [1,2-a ] pyridine as claimed in claim 1, characterized in that: the amount of the catalyst substance is 1-5% of the amount of the 2-amino-4-fluoropyridine substance.
5. The copper complex-promoted synthesis of 7-fluoroimidazo [1,2-a ] pyridine as claimed in claim 1, characterized in that: the peroxide is selected from sodium persulfate, Oxone, benzoyl peroxide and the like, and the amount ratio of the peroxide to the 2-amino-4-fluoropyridine is 1-1.2: 1.
6. the copper complex-promoted synthesis of 7-fluoroimidazo [1,2-a ] pyridine as claimed in claim 1, characterized in that: the acetylene consumption of the reaction is measured by the pressure of acetylene gas in a reaction system, and the pressure of acetylene is kept at 1-5 standard atmospheric pressures in the reaction process.
7. The copper complex-promoted synthesis of 7-fluoroimidazo [1,2-a ] pyridine as claimed in claim 1, characterized in that: the solvent for the reaction is selected from DMF (N, N-dimethylformamide), DMA (N, N-dimethylacetamide), DMSO (dimethyl sulfoxide), acetonitrile and the like.
8. The copper complex-promoted synthesis of 7-fluoroimidazo [1,2-a ] pyridine as claimed in claim 1, characterized in that: the reaction temperature is 60-100 ℃.
CN202010562549.5A 2020-06-18 2020-06-18 Copper complex promoted 7-fluoroimidazo [1,2-a ] pyridine synthesis method Pending CN111635401A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010562549.5A CN111635401A (en) 2020-06-18 2020-06-18 Copper complex promoted 7-fluoroimidazo [1,2-a ] pyridine synthesis method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010562549.5A CN111635401A (en) 2020-06-18 2020-06-18 Copper complex promoted 7-fluoroimidazo [1,2-a ] pyridine synthesis method

Publications (1)

Publication Number Publication Date
CN111635401A true CN111635401A (en) 2020-09-08

Family

ID=72327555

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010562549.5A Pending CN111635401A (en) 2020-06-18 2020-06-18 Copper complex promoted 7-fluoroimidazo [1,2-a ] pyridine synthesis method

Country Status (1)

Country Link
CN (1) CN111635401A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112409354A (en) * 2020-12-23 2021-02-26 苏利制药科技江阴有限公司 Synthesis process of 7-fluoroimidazo [1,2-A ] pyridine and intermediate thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102838597A (en) * 2012-09-10 2012-12-26 武汉大学 Preparation method of heteroaromatic iminazole [1,2-Alpha]pyridine compounds
CN106065009A (en) * 2014-06-28 2016-11-02 广东东阳光药业有限公司 As the compound of hepatitis c inhibitor and the application in medicine thereof
WO2017005822A1 (en) * 2015-07-06 2017-01-12 Paris Sciences Et Lettres - Quartier Latin Functionalizable molecular probe for x-ray fluorescence imaging and multimodal imaging
CN110467591A (en) * 2019-08-23 2019-11-19 上海克琴科技有限公司 Rare earth metal complex promote one pot process cosmetic active object Bose because

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102838597A (en) * 2012-09-10 2012-12-26 武汉大学 Preparation method of heteroaromatic iminazole [1,2-Alpha]pyridine compounds
CN106065009A (en) * 2014-06-28 2016-11-02 广东东阳光药业有限公司 As the compound of hepatitis c inhibitor and the application in medicine thereof
WO2017005822A1 (en) * 2015-07-06 2017-01-12 Paris Sciences Et Lettres - Quartier Latin Functionalizable molecular probe for x-ray fluorescence imaging and multimodal imaging
CN110467591A (en) * 2019-08-23 2019-11-19 上海克琴科技有限公司 Rare earth metal complex promote one pot process cosmetic active object Bose because

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112409354A (en) * 2020-12-23 2021-02-26 苏利制药科技江阴有限公司 Synthesis process of 7-fluoroimidazo [1,2-A ] pyridine and intermediate thereof
CN112409354B (en) * 2020-12-23 2021-10-08 苏利制药科技江阴有限公司 Synthesis process of 7-fluoroimidazo [1,2-A ] pyridine and intermediate thereof

Similar Documents

Publication Publication Date Title
CN105801575B (en) A kind of synthetic method of imidazo [1,2-a] pyridine
US6180799B1 (en) Sulfalation of tetraol
CN112062756A (en) Mannhouse donor-acceptor adduct of furan and 3-pyridine ethylamine activated by Merlox acid and synthetic method thereof
CN112679420A (en) Preparation method of 2,5-dibromopyridine
CN114634482B (en) Diazonium difluoro methylation reagent and synthetic method and application thereof
CN103145600B (en) Synthesis method of silver-catalyzed polysubstitued pyrrole compounds
CN111635401A (en) Copper complex promoted 7-fluoroimidazo [1,2-a ] pyridine synthesis method
CN113416150A (en) Novel synthesis method of lobaplatin intermediate
CN104710417B (en) Azaindole derivatives and synthesis method thereof
CN113735752B (en) Method for preparing isothiourea compound based on substituted iodobenzene
CN111253331B (en) Method for synthesizing spiroisoxazoline by using dihydrochalcone as raw material
CN108558974B (en) Preparation and application of sugar-derived nickel pyridine triazole catalyst
CN109251174B (en) 3-trinitromethylpyrazole compounds
CN113354573B (en) Method for large-scale production of alpha, alpha-terpyridine
CN115572263B (en) Method for synthesizing pyrazoline by catalyzing ketazine cyclization with hydrazine salt
Deng et al. Ring A conformation of aconine and pseudaconine in CDCl3
CN115010656B (en) Preparation method of 5-acetyl-2-bromopyridine
CN110818647B (en) Preparation method of heptatomic ring urea compound
CN111675668B (en) TEMPO-catalyzed reaction method for synthesizing spiroisoxazoline by taking oxime compound as raw material
CN107501024A (en) A kind of synthetic method of 1,2 2 iodo alkenes compounds
CN108276305B (en) Mild method for preparing Sudan red I structural analogue
CN108558751B (en) Synthesis process of 3-nitroquinoline derivative
CN115784967A (en) Synthesis method of nitroisoindolinone compounds
CN114773301A (en) Method for synthesizing furan compound from terminal alkyne and iodine ylide
CN116462624A (en) Preparation method of cyclobutene derivative

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200908